Use of anti‐CMV immunoglobulins in lung transplant recipients: The French experience-Reference-Cited by-同舟云学术

Use of anti‐CMV immunoglobulins in lung transplant recipients: The French experience

Published:2021-11-12 Issue:6 Volume:23 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transplant Infectious Dis

Author:

Charlotte Roy¹^ORCID,François Parquin²,Jonathan Messika³^ORCID,Véronique Boussaud⁴,Olivier Brugière¹,Tristan Degot⁵,Séverine Feuillet⁶,Jérôme Lepavec⁶,Adrien Tissot⁷,Claire Dromer⁸,Espérie Burnet⁴,Eve Camps⁹,Antoine Roux¹¹⁰

Affiliation:

1. Pulmonology Department Adult Cystic Fibrosis Centre and Lung Transplantation Department Foch Hospital Suresnes France

2. Thoracic Intensive Care Unit Foch Hospital Suresnes France

3. Pulmonology Department and Lung Transplant Centre Bichat Hospital Assistance Publique‐Hôpitaux de Paris France

4. Pulmonology Department Cochin Hospital Assistance Publique‐Hôpitaux de Paris France

5. Department of Respiratory Medicine Strasbourg University Hospital Strasbourg France

6. Department of Cardio‐Thoracic Surgery and Heart‐Lung Transplantation Hôpital Marie‐Lannelongue Le Plessis‐Robinson France

7. Pulmonology Department Institut du Thorax Nantes University Hospital Nantes France

8. Pulmonology Department Bordeaux University Hospital Bordeaux France

9. Pharmacy Department Foch Hospital Suresnes France

10. Versailles‐Saint‐Quentin‐en‐Yvelines University Versailles France

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13754

Reference29 articles.

1. Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice

2. Clinical predictors of progression and clearance of low‐level CMV DNAemia in solid organ transplant recipients

3. Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis

4. Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients

5. Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and Treatment;Viruses;2024-09-07

2. Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management. A report from the CMV International Symposium 2023;Transplant Infectious Disease;2023-11-09

3. Epidemiology, Drug Resistance, and Risk Factors for Mortality Among Hematopoietic Stem Cell Transplantation Recipients with Hospital-Acquired Klebsiella pneumoniae Infections: A Single-Center Retrospective Study from China;Infection and Drug Resistance;2022-08

4. Erratum;Transplant Infectious Disease;2022-03-25